InsiderTrades.com logo

WHWK Insider Trading

Insider Ownership Percentage: 49.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,584,564.00

Whitehawk Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Whitehawk Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Whitehawk Therapeutics Share Price & Price History

Current Price: $3.79
Price Change: ▼ Price Decrease of -0.04 (-1.04%)
As of 07/24/2026 12:01 PM ET

This chart shows the closing price history over time for WHWK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Whitehawk Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2026Scott M. GiacobelloCFOSell141,600$4.13$584,808.00295,224View SEC Filing Icon  
4/15/2026Scott M. GiacobelloCFOSell77,000$3.86$297,220.00436,824View SEC Filing Icon  
4/14/2026Bryan BallInsiderSell92,460$3.64$336,554.40397,106View SEC Filing Icon  
4/13/2026Bryan BallInsiderSell26,389$3.46$91,305.94489,566View SEC Filing Icon  
4/10/2026Bryan BallInsiderSell6,596$3.43$22,624.28515,955View SEC Filing Icon  
4/9/2026Bryan BallInsiderSell50,000$3.57$178,500.00522,551View SEC Filing Icon  
4/9/2026David James LennonCEOSell14,500$3.38$49,010.00518,622View SEC Filing Icon  
4/8/2026David James LennonCEOSell63,945$3.40$217,413.00533,122View SEC Filing Icon  
4/7/2026David James LennonCEOSell94,087$3.43$322,718.41597,067View SEC Filing Icon  
4/6/2026David James LennonCEOSell102,395$3.51$359,406.45691,154View SEC Filing Icon  
4/2/2026David James LennonCEOSell26,858$3.48$93,465.84793,549View SEC Filing Icon  
3/2/2026Bryan BallInsiderSell1,834$3.31$6,070.54206,019View SEC Filing Icon  
3/2/2026David James LennonCEOSell5,100$3.31$16,881.0044,579View SEC Filing Icon  
3/2/2026Scott M. GiacobelloCFOSell2,594$3.31$8,586.1428,100View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Whitehawk Therapeutics (NASDAQ:WHWK)

52.08% of Whitehawk Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at WHWK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Whitehawk Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP54,296$0.19M0.1%N/A0.110%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE52,861$0.18M0.0%+12,761.6%0.107%Search for SEC Filing on Google Icon
5/19/2026Stempoint Capital LP939,369$3.24M0.6%-35.6%1.900%Search for SEC Filing on Google Icon
5/18/2026ADAR1 Capital Management LLC128,503$0.44M0.0%+65.6%0.260%Search for SEC Filing on Google Icon
5/18/2026Eversept Partners LP306,800$1.06M0.1%+17.9%0.620%Search for SEC Filing on Google Icon
5/15/2026OMERS ADMINISTRATION Corp11,500$40K0.0%N/A0.023%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC428,622$1.48M0.0%-2.7%0.867%Search for SEC Filing on Google Icon
2/18/2026KVP Capital Advisors LP2,165,997$5.24M5.1%N/A4.596%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd15,704$38K0.0%-20.6%0.033%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd11,447$28K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP260,259$0.63M0.0%N/A0.552%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC77,593$0.19M0.0%N/A0.165%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP67,959$0.16M0.0%N/A0.144%Search for SEC Filing on Google Icon
2/13/2026State Street Corp145,537$0.35M0.0%+111.7%0.309%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC69,931$0.17M0.0%+177.3%0.148%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC440,722$1.07M0.0%-3.7%0.935%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP28,641$69K0.0%-35.1%0.061%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC425,440$1.03M0.0%+11.4%0.903%Search for SEC Filing on Google Icon
11/17/2025Acorn Capital Advisors LLC1,139,363$2.17M1.1%N/A2.418%Search for SEC Filing on Google Icon
11/17/2025Yu Fan2,070,000$3.93M5.1%N/A4.392%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC140,220$0.27M0.0%N/A0.298%Search for SEC Filing on Google Icon
11/17/2025Ally Bridge Group NY LLC817,939$1.55M0.9%N/A1.735%Search for SEC Filing on Google Icon
11/17/2025ABG Innovation Capital Partners III GP Ltd26,666$51K100.0%N/A0.057%Search for SEC Filing on Google Icon
11/14/2025Orbimed Advisors LLC4,166,000$7.92M0.2%N/A8.840%Search for SEC Filing on Google Icon
11/14/2025Acuta Capital Partners LLC3,410,402$6.48M6.7%N/A7.236%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC215,284$0.41M0.0%N/A0.457%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC83,660$0.16M0.0%N/A0.178%Search for SEC Filing on Google Icon
11/14/2025Suvretta Capital Management LLC3,700,000$7.03M0.2%N/A7.851%Search for SEC Filing on Google Icon
11/14/2025Avoro Capital Advisors LLC2,849,402$5.41M0.1%N/A6.046%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP44,115$84K0.0%N/A0.094%Search for SEC Filing on Google Icon
11/10/2025Peapod Lane Capital LLC303,585$0.58M0.5%N/A0.644%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,342,907$2.55M0.0%N/A2.849%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Whitehawk Therapeutics logo
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Read More on Whitehawk Therapeutics

Today's Range

Now: $3.79
Low: $3.74
High: $3.85

50 Day Range

MA: $4.22
Low: $3.79
High: $4.78

52 Week Range

Now: $3.79
Low: $1.57
High: $5.49

Volume

150,930 shs

Average Volume

303,105 shs

Market Capitalization

$187.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Who are the company insiders with the largest holdings of Whitehawk Therapeutics?

Whitehawk Therapeutics' top insider investors include:
  1. David James Lennon (CEO)
  2. Bryan Ball (Insider)
  3. Scott M Giacobello (CFO)
Learn More about top insider investors at Whitehawk Therapeutics.

Whitehawk Therapeutics Active Insiders

David James Lennon
David James Lennon
President & CEO
6 recent trades
Scott M Giacobello
Scott M Giacobello
CFO
3 recent trades
Bryan Ball
Bryan Ball
Chief Technical Operations Officer
5 recent trades